As the name of our company suggests, an integral element of SCI’s culture is collaboration. We recognize the importance of ongoing dialogue with our clients so that we can incorporate the perspectives of an interdisciplinary team into the statistical thinking. For nearly thirty years, we have maintained our dedication to fostering:
Our statisticians, statistical programmers, and research assistants are proud to offer deep expertise, scientific rigor, and statistical validity. Creating and actively contributing to our collective understanding of data—and knowing how to integrate that data across various disciplines—is central to everything we do.
Our culture is one that values scientific integrity and knowledge—but we also value the people behind the numbers.
Part of what makes us unique is our collaborative, friendly, engaging, and team-oriented environment. Our transparency, cooperation, and guidance have resulted in genuine, long-standing relationships—not only with each other, but with our clients.
We are a company driven by our values. Our style and decisions reflect our core ideals:
We tell the truth no matter what, and are committed to recognizing what we know and do not know.
We take personal responsibility and accountability for all we do.
We are consistently conscientious and thorough.
We approach all projects with scientific and intellectual integrity from start to finish.
We seek out and respect others’ opinions, knowing that we need collective involvement to produce high-quality work.
Statistics Collaborative, Inc. (SCI) was founded in 1990 by Janet Wittes, PhD. With nearly three decades of experience, we specialize in providing biostatistical consulting services for clients developing drugs, biologics, and medical devices. Learn more about our collaborative approach here.
While our primary expertise lies in clinical trials, we also work with epidemiological studies, preclinical studies, and non-clinical research across a wide range of therapeutic areas. Our dedicated and experienced staff collaborates across industry, non-profit organizations, government agencies, and academic settings.
Our statistical expertise includes trial design, reporting for Data Monitoring Committees, data analysis, and consultation for FDA presentations. We work in therapeutic areas related to drug development, with special emphasis on cardiovascular disease, oncology, infectious disease, orphan diseases, and vaccines.
We work closely with our clients to develop research programs with scientific rigor and statistical validity, and are committed to maintaining the highest scientific and ethical standards.
To contact SCI about a potential project, please call us at 202.247.9700 or click below.